Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 9, Issue 4, 2007, Pages 327-338

  Fabietti, Pier Giorgio ^a   Canonico, Valentina ^a   Orsini Federici, Marco ^a   Sarti, Eugenio ^a   Massi Benedetti, Massimo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN LISPRO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; SIMULATION; VALIDATION STUDY;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN INFUSION SYSTEMS; LIVER; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS;

EID: 34548304090     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.0030     Document Type: Article

References (40)

1. Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W: An artificial endocrine pancreas. Diabetes 1974;23:389-404.
2. Pfeiffer EF, Thum C, Clemens AH: The artificial beta cell - a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res 1974;6:339-342.
3. Clemens AH, Chung PH, Myers RW: Development of Biostator, a glucose controlled insulin infusion system (GCIIS). Horm Metab Res Suppl 1977;7:23-33.
4. Massi Benedetti M, Noy G, Johnston IDA, Worth R, Alberti KGMM: Glucose controlled insulin infusion system (Biostator) application during surgery for a presumed pancreatic microinsulinoma. Diabetes Metab 1981;7:41-44.
5. Massi Benedetti M, Home PD, Gill GV, Burrin JM, Noy GA, Alberti KGMM: Hormonal and metabolic responses in brittle diabetic patients during feedback intravenous insulin infusion. Diabetes Res Clin Pract 1987;3:307-317.
6. Heinemann L, Ampudia-Blasco FJ: Glucose clamps with the Biostator: a critical reappraisal. Horm Metab Res 1994;26:579-583.
7. Ishii M, Nakamura T, Kasai F, Baba T, Takebe K: Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis. Diabetes Care 1997;20:1134-1137.
8. Brunetti P, Puxeddu A, Calabrese G, Massi Benedetti M, Santeusanio F, Bolli G, Scionti L, Bueti A, Angeletti G: Therapeutical application of artificial beta-cell in surgery and obstetrics. Horm Metab Res Suppl 1979;8:162-165.
9. Massi Benedetti M, Puxeddu A, Calabrese G, Mercati U, Cortesini R, Santeusanio F, Alfani D, Trancanelli V, Antonella MA, Brunetti P: Use of the artificial endocrine pancreas during surgery. In: Brunetti P, Alberti KGMM, Albisser AM, Hepp KD, Massi Benedetti M, eds. Artificial Systems for Insulin Delivery. New York: Raven Press, 1983:525-533.
10. Fabietti PG, Massi Benedetti M, Bronzo F, Reboldi GP, Sarti E, Brunetti P: Wearable system for acquisition, processing and storage of the signal from amperometric glucose sensors. Int J Artif Organs 1991;14:175-178.
11. Pickup J, McCartney L, Rolinski O, Birch D: In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring. BMJ 1999;319:1289-1295.
12. Fabietti PG, Calabrese G, Iorio M, Bistoni S, Brunetti P, Sarti E, Benedetti MM: A mathematical model describing the glycemic response of diabetic patients to meal and i.v. infusion of insulin. Int J Artif Organs 2001;24:736-742.
13. Heinemann L, Koschinsky T: Continuous glucose monitoring: an overview of today's technologies and their clinical applications. Int J Clin Pract Suppl 2002;129:75-79.
14. Brunetti P, Orsini Federici M, Massi Benedetti M: The artificial pancreas. Artif Cells Blood Substit Immobil Biotechnol 2003;31:127-138.
15. Shichiri M, Kawamori R, Yamasaki Y, Hakui N, Abe H: Wearable artificial endocrine pancreas with needle-type glucose sensor. Lancet 1982;2:1129-1131.
16. Renard E, Costalat G, Bringer J: From external to implantable insulin pump, can we close the loop? Diabetes Metab 2002;28(4 Pt 2):2S19-2S25.
17. Hovorka R, Chassin LJ, Wilinska ME, Canonico V, Akwi JA, Orsini Federici M, Massi-Benedetti M, Hutzli I, Zaugg C, Kaufmann H, Both M, Vering T, Schaller HC, Schaupp L, Bodenlenz M, Pieber TR: Closing the loop: the Adicol experience. Diabetes Technol Ther 2004;6:307-318.
18. Sachedina N, Pickup JC: Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects. Diabet Med 2003;20:1012-1015.
19. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M: Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002;25:347-352.
20. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29:44-50.
21. Mauras N, Beck RW, Ruedy KJ, Kollman C, Tamborlane WV, Chase HP, Buckingham BA, Tsalikian E, Weinzimer S, Booth AD, Xing D; Diabetes Research in Children Network (DirecNet) Accuracy Study: Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. J Pediatr 2004;144:770-775.
22. Guerci B, Floriot M, Bohme P, Durain D, Benichou M, Jellimann S, Drouin P: Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogues. Diabetes Care 200326:582-589.
23. Cobelli C, Mari A: Control of diabetes with artificial systems for insulin delivery - algorithm independent limitations revealed by a modelling study. IEEE Trans Biomed Eng 1985;32:840-845.
24. Chen JW, Christiansen JS, Lauritzen T: Limitations to subcutaneous insulin administration in type 1 diabetes. Diabetes Obes Metab 2003;5:223-233.
25. Fabietti PG, Canonico V, Orsini Federici M, Benedetti MM, Sarti E: Control oriented model of insulin and glucose dynamics in type 1 diabetics. Med Biol Eng Comput 2006;44:69-78.
26. Bergman RN, Cobelli C: Physiological evaluation of factors controlling glucose tolerance in men: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456-1467.
27. Cobelli C, Toffolo G: A model of glucose kinetics and their control by insulin, compartmental and non-compartmental approaches. Math Biosci 1984;72:291-235.
28. Arleth T, Andreassen S, Orsini Federici M, Massi Benedetti M: A model of the endogenous glucose balance incorporating the characteristics of glucose transporters. Comput Methods Programs Biomed 2000;62:219-234.
29. nd ed. New York: Wiley, 1997:505-530.
30. Wise S, Nielsen M, Rizza R: Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contribution of glycogenolysis and gluconeogenesis to endogenous glucose production. J Clin Endocrinol Metab 1997;82:1828-1833.
31. Canonico V, Orsini Federici M, Ferolla P, Celleno R, Akwe J, Timi A, Chassis L, Wilinska M, Vering T, Hovorka R, Massi Benedetti M: Evaluation of a feedback model based on simulated interstitial glucose for continuous insulin infusion [abstract 995]. Diabetologia 2002;45(Suppl 1):A322.
32. Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Orsini Federici M, Pieber TR, Schaller HC, Schaupp L, Vering T, Wilinska ME: Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas 2004;25:905-920.
33. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.
34. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999;46:183-190.
35. Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E: The glucose area under the profiles obtained with Continuous Glucose Monitoring System relationships with HbA1c in pediatric type 1 diabetic patients. Diabetes Care 2002;25:1840-1844.
36. McGowan K, Thomas W, Moran A: Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002;25:1499-1503.
37. Shichiri M, Kawamori R, Hakui N, Yamasaki Y, Abe H: Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response. Diabetes 1984;33:1200-1202.
38. Calabrese G, Bueti A, Zega G, Giombolini G, Bellomo G, Antonella MA, Massi Benedetti M, Brunetti P: Improvement of artificial endocrine pancreas (Biostator; GCIIS) performance combining feedback controlled insulin administration with a pre-programmed insulin infusion. Horm Metab Res 1982;14:505-506.
39. Reboldi GP, Home PD, Calabrese G, Fabietti PG, Brunetti P, Massi Benedetti M: Time delay compensation for closed-loop insulin delivery systems: a simulation study. Int J Artif Organs 1991;14:350-358.
40. Stephenson JM, Schernthaner G: Dawn phenomenon and Somogyi effect in IDDM. Diabetes Care 1989;12:245-251.